Kevy's Generics Private Limited, a active private limited company, was established on 14 May 2008 in Hyderabad, Telangana, India. Engaging in industrial chemicals within the manufacturing sector, it holds CIN: U24233TG2008PTC059172. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹1.11 Cr and a paid-up capital of ₹1.10 Cr.
Formerly known as G M S Pharmaceuticals Private Limited. It upholds a compliant status. Its leadership includes Veeraiah Kavuri (Managing Director), Venkata Rama Rao Edupuganti (Director), Srinivasa Reddy Annapu Reddy (Director). Past directors included Lakshmi Narasimha Murthy Maremanda, Guttula Chandra Rao, Veeraiah Kavuri. It holds ₹27.09 Cr open charges and ₹3.15 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at H.No.A-32, Apuroopa Colony, Ida Jeedimetla, Hyderabad, Telangana, 500055.
U24233TG2008PTC059172
059172
14 May 2008
₹1.11 Cr
₹1.10 Cr
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Kevy's Generics Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Veeraiah Kavuri | Managing Director | 12 Feb 2013 | Current |
| Venkata Rama Rao Edupuganti | Director | 03 Mar 2014 | Current |
| Srinivasa Reddy Annapu Reddy | Director | 12 Feb 2013 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 04 Apr 2013 | Past |
| Pramod Abcsdd | Director | 04 Apr 2013 | Past |
| Pramod Abcsdd | Director | 25 Jul 2013 | Past |
| Pramod Abcsdd | Director | 06 Feb 2013 | Past |
| Pramod Abcsdd | Director | 04 Apr 2013 | Past |
| Pramod Abcsdd | Director | 04 Apr 2013 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Kevy'S Generics Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 31.33% increase. The company also saw a substantial improvement in profitability, with a 6741.07% increase in profit. The company's net worth moved up by a moderate rise of 5.29%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Kevy'S Generics had a public holding of 11.18%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹270,900,000.00
₹31,500,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 Aug 2022 | Hdfc Bank Limited | ₹1.09 Cr | Open |
| 29 Sep 2021 | Hdfc Bank Limited | ₹26.00 Cr | Open |
| 06 Sep 2013 | Others | ₹3.15 Cr | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Kevy'S Generics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Kevy'S Generics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kevy'S Generics's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
A charge with Hdfc Bank Limited of Rs. 26.00 Cr registered on 29 Sep 2021 with Charge ID 100489225 was modified on 13 Jan 2025. was recorded as a recent event.
Kevy'S Generics Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Progress on Kevy'S Generics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was documented.
A charge with Hdfc Bank Limited amounted to Rs. 1.09 Cr with Charge ID 100610485 was registered on 27 Aug 2022. was recorded as a recent event.
Progress on A charge registered on 06 Sep 2013 via Charge ID 10454676 with Others was fully satisfied on 10 Aug 2022. was documented.
A charge with Hdfc Bank Limited amounted to Rs. 26.00 Cr with Charge ID 100489225 was registered on 29 Sep 2021. was recorded as a recent event.
The CIN of Kevy's Generics Private Limited is U24233TG2008PTC059172.
Kevy's Generics Private Limited is headquartered at H.No.A-32, Apuroopa Colony, Ida Jeedimetla, Hyderabad, Telangana, 500055.
Kevy's Generics Private Limited was incorporated on 14 May 2008.
The current directors of Kevy's Generics Private Limited are
The primary industry of Kevy's Generics Private Limited is Manufacturing.
Kevy's Generics Private Limited is unlisted.
The authorized capital of Kevy's Generics Private Limited is ₹1.11 Cr, and the paid-up capital is ₹1.10 Cr.
The compliance status of Kevy's Generics Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX